There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
1 response
7,294 views
0 reactions
|
by Exeplex
10-29-2009, 06:12 AM
|
|||
|
2 responses
5,818 views
0 reactions
|
by Nihilo
10-13-2009, 11:08 AM
|
|||
|
1 response
2,732 views
0 reactions
|
by shurjo
10-13-2009, 09:20 AM
|
|||
|
1 response
3,783 views
0 reactions
|
by elaney_k
10-07-2009, 03:36 AM
|
|||
|
3 responses
6,689 views
0 reactions
|
by wakskat
09-18-2009, 08:26 AM
|
|||
|
0 responses
3,944 views
0 reactions
|
by der_eiskern
09-15-2009, 06:12 PM
|
|||
|
0 responses
2,825 views
0 reactions
|
09-08-2009, 09:22 AM
|
|||
|
0 responses
4,754 views
0 reactions
|
by C.Griffin
09-06-2009, 12:37 AM
|
|||
|
7 responses
9,516 views
0 reactions
|
by kmcarr
09-01-2009, 09:58 AM
|
|||
|
1 response
4,269 views
0 reactions
|
by Susanne
08-26-2009, 05:14 AM
|
No topics found.
-
Next-generation sequencing (NGS) is changing how clinical and public health laboratories detect pathogens, track antimicrobial resistance,...10-01-2026, 05:37 AM -
Much of the genetic basis of Alzheimer's disease and related dementias (AD/ADRD) is still unexplained, and some of the answers may sit...10-01-2026, 05:06 AM
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing... -
The immune system’s power comes from its genetic diversity, allowing myriad threats to be neutralized through first recognizing foreign antigens. That diversity is also what makes the immune system so difficult to study. Recent advances in sequencing technology and computational biology, however, are giving researchers new tools to understand immune responses and immune-related diseases in greater detail.
This convergence of genetics, immunology, and computation...09-01-2026, 05:41 AM